Acoustically responsive polydopamine nanodroplets

A novel theranostic agent

Christophoros Mannaris, Chuanxu Yang, Dario Carugo, Joshua Owen, Jeong Yu Lee, Sandra Nwokeoha, Anjali Seth, Boon Mian Teo

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Ultrasound-induced cavitation has been used as a tool of enhancing extravasation and tissue penetration of anticancer agents in tumours. Initiating cavitation in tissue however, requires high acoustic intensities that are neither safe nor easy to achieve with current clinical systems. The use of cavitation nuclei can however lower the acoustic intensities required to initiate cavitation and the resulting bio-effects in situ. Microbubbles, solid gas-trapping nanoparticles, and phase shift nanodroplets are some examples in a growing list of proposed cavitation nuclei. Besides the ability to lower the cavitation threshold, stability, long circulation times, biocompatibility and biodegradability, are some of the desirable characteristics that a clinically applicable cavitation agent should possess. In this study, we present a novel formulation of ultrasound-triggered phase transition sub-micrometer sized nanodroplets (~400 nm) stabilised with a biocompatible polymer, polydopamine (PDA). PDA offers some important benefits: (1) facile fabrication, as dopamine monomers are directly polymerised on the nanodroplets, (2) high polymer biocompatibility, and (3) ease of functionalisation with other molecules such as drugs or targeting species. We demonstrate that the acoustic intensities required to initiate inertial cavitation can all be achieved with existing clinical ultrasound systems. Cell viability and haemolysis studies show that nanodroplets are biocompatible. Our results demonstrate the great potential of PDA nanodroplets as an acoustically active nanodevice, which is highly valuable for biomedical applications including drug delivery and treatment monitoring.

Original languageEnglish
Article number104782
Number of pages7
JournalUltrasonics Sonochemistry
Volume60
DOIs
Publication statusPublished - Jan 2020

Keywords

  • Acoustic droplet vaporization
  • Nanodroplets
  • Polydopamine
  • Ultrasound

Cite this

Mannaris, Christophoros ; Yang, Chuanxu ; Carugo, Dario ; Owen, Joshua ; Lee, Jeong Yu ; Nwokeoha, Sandra ; Seth, Anjali ; Teo, Boon Mian. / Acoustically responsive polydopamine nanodroplets : A novel theranostic agent. In: Ultrasonics Sonochemistry. 2020 ; Vol. 60.
@article{a2782380719a4206a6bc0a1863d9139d,
title = "Acoustically responsive polydopamine nanodroplets: A novel theranostic agent",
abstract = "Ultrasound-induced cavitation has been used as a tool of enhancing extravasation and tissue penetration of anticancer agents in tumours. Initiating cavitation in tissue however, requires high acoustic intensities that are neither safe nor easy to achieve with current clinical systems. The use of cavitation nuclei can however lower the acoustic intensities required to initiate cavitation and the resulting bio-effects in situ. Microbubbles, solid gas-trapping nanoparticles, and phase shift nanodroplets are some examples in a growing list of proposed cavitation nuclei. Besides the ability to lower the cavitation threshold, stability, long circulation times, biocompatibility and biodegradability, are some of the desirable characteristics that a clinically applicable cavitation agent should possess. In this study, we present a novel formulation of ultrasound-triggered phase transition sub-micrometer sized nanodroplets (~400 nm) stabilised with a biocompatible polymer, polydopamine (PDA). PDA offers some important benefits: (1) facile fabrication, as dopamine monomers are directly polymerised on the nanodroplets, (2) high polymer biocompatibility, and (3) ease of functionalisation with other molecules such as drugs or targeting species. We demonstrate that the acoustic intensities required to initiate inertial cavitation can all be achieved with existing clinical ultrasound systems. Cell viability and haemolysis studies show that nanodroplets are biocompatible. Our results demonstrate the great potential of PDA nanodroplets as an acoustically active nanodevice, which is highly valuable for biomedical applications including drug delivery and treatment monitoring.",
keywords = "Acoustic droplet vaporization, Nanodroplets, Polydopamine, Ultrasound",
author = "Christophoros Mannaris and Chuanxu Yang and Dario Carugo and Joshua Owen and Lee, {Jeong Yu} and Sandra Nwokeoha and Anjali Seth and Teo, {Boon Mian}",
year = "2020",
month = "1",
doi = "10.1016/j.ultsonch.2019.104782",
language = "English",
volume = "60",
journal = "Ultrasonics Sonochemistry",
issn = "1350-4177",
publisher = "Elsevier",

}

Acoustically responsive polydopamine nanodroplets : A novel theranostic agent. / Mannaris, Christophoros; Yang, Chuanxu; Carugo, Dario; Owen, Joshua; Lee, Jeong Yu; Nwokeoha, Sandra; Seth, Anjali; Teo, Boon Mian.

In: Ultrasonics Sonochemistry, Vol. 60, 104782, 01.2020.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Acoustically responsive polydopamine nanodroplets

T2 - A novel theranostic agent

AU - Mannaris, Christophoros

AU - Yang, Chuanxu

AU - Carugo, Dario

AU - Owen, Joshua

AU - Lee, Jeong Yu

AU - Nwokeoha, Sandra

AU - Seth, Anjali

AU - Teo, Boon Mian

PY - 2020/1

Y1 - 2020/1

N2 - Ultrasound-induced cavitation has been used as a tool of enhancing extravasation and tissue penetration of anticancer agents in tumours. Initiating cavitation in tissue however, requires high acoustic intensities that are neither safe nor easy to achieve with current clinical systems. The use of cavitation nuclei can however lower the acoustic intensities required to initiate cavitation and the resulting bio-effects in situ. Microbubbles, solid gas-trapping nanoparticles, and phase shift nanodroplets are some examples in a growing list of proposed cavitation nuclei. Besides the ability to lower the cavitation threshold, stability, long circulation times, biocompatibility and biodegradability, are some of the desirable characteristics that a clinically applicable cavitation agent should possess. In this study, we present a novel formulation of ultrasound-triggered phase transition sub-micrometer sized nanodroplets (~400 nm) stabilised with a biocompatible polymer, polydopamine (PDA). PDA offers some important benefits: (1) facile fabrication, as dopamine monomers are directly polymerised on the nanodroplets, (2) high polymer biocompatibility, and (3) ease of functionalisation with other molecules such as drugs or targeting species. We demonstrate that the acoustic intensities required to initiate inertial cavitation can all be achieved with existing clinical ultrasound systems. Cell viability and haemolysis studies show that nanodroplets are biocompatible. Our results demonstrate the great potential of PDA nanodroplets as an acoustically active nanodevice, which is highly valuable for biomedical applications including drug delivery and treatment monitoring.

AB - Ultrasound-induced cavitation has been used as a tool of enhancing extravasation and tissue penetration of anticancer agents in tumours. Initiating cavitation in tissue however, requires high acoustic intensities that are neither safe nor easy to achieve with current clinical systems. The use of cavitation nuclei can however lower the acoustic intensities required to initiate cavitation and the resulting bio-effects in situ. Microbubbles, solid gas-trapping nanoparticles, and phase shift nanodroplets are some examples in a growing list of proposed cavitation nuclei. Besides the ability to lower the cavitation threshold, stability, long circulation times, biocompatibility and biodegradability, are some of the desirable characteristics that a clinically applicable cavitation agent should possess. In this study, we present a novel formulation of ultrasound-triggered phase transition sub-micrometer sized nanodroplets (~400 nm) stabilised with a biocompatible polymer, polydopamine (PDA). PDA offers some important benefits: (1) facile fabrication, as dopamine monomers are directly polymerised on the nanodroplets, (2) high polymer biocompatibility, and (3) ease of functionalisation with other molecules such as drugs or targeting species. We demonstrate that the acoustic intensities required to initiate inertial cavitation can all be achieved with existing clinical ultrasound systems. Cell viability and haemolysis studies show that nanodroplets are biocompatible. Our results demonstrate the great potential of PDA nanodroplets as an acoustically active nanodevice, which is highly valuable for biomedical applications including drug delivery and treatment monitoring.

KW - Acoustic droplet vaporization

KW - Nanodroplets

KW - Polydopamine

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85072277555&partnerID=8YFLogxK

U2 - 10.1016/j.ultsonch.2019.104782

DO - 10.1016/j.ultsonch.2019.104782

M3 - Article

VL - 60

JO - Ultrasonics Sonochemistry

JF - Ultrasonics Sonochemistry

SN - 1350-4177

M1 - 104782

ER -